Company · Ownership research

Mineralys Therapeutics, Inc. MLYS

CIK 0001933414

Form 4 transactions dated Nov 1, 2023 to Nov 10, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 49 rows; the complete set is available through the API.

Insider filings on file run through Oct 20, 2026.

Insider purchases & sales

Purchased: $98.49M
Sold: $104.81M

Nov 1, 2023 – Oct 20, 2026
Available records · partial months are marked ·

202610 of 30 preview events · 49 available in 2026

Date	Insider	Activity	Trade value (USD)	% of prior holding
Sep 30, 2026	Congleton Jon Chief Executive Officer · Director	Sale10b5-1 footnote	$1.91M 75,000 shares sold	12.43% sold Direct holding	▾
Sep 22, 2026	Slingsby Brian Taylor Director	Sale	$3.01M 104,320 shares sold	1.32% sold Indirect holding	▾
Sep 21, 2026	Warren Eric Chief Commercial Officer	Sale10b5-1 footnote	$209.14K 7,438 shares sold	16.23% sold Direct holding	▾
Sep 15, 2026	Karydas Daphne Director	Sale10b5-1 footnote	$85.74K 3,000 shares sold	32.61% sold Direct holding	▾
Aug 21, 2026	Warren Eric Chief Commercial Officer	Sale10b5-1 footnote	$193.19K 7,437 shares sold	16.22% sold Direct holding	▾
Aug 10, 2026	Rodman David Malcom Chief Medical Officer	Sale10b5-1 footnote	$58.79K 2,170 shares sold	4.05% sold Direct holding	▾
Jul 21, 2026	Warren Eric Chief Commercial Officer	Sale10b5-1 footnote	$199.89K 7,438 shares sold	16.23% sold Direct holding	▾
Jul 17, 2026	Rodman David Malcom Chief Medical Officer	Sale10b5-1 footnote	$11.04K 416 shares sold	0.80% sold Direct holding	▾
Jul 15, 2026	Rodman David Malcom Chief Medical Officer	Sale10b5-1 footnote	$168.95K 6,349 shares sold	11.00% sold Direct holding	▾
Jul 13, 2026	Congleton Jon Chief Executive Officer · Director	Sale10b5-1 footnote	$291.44K 10,700 shares sold	1.74% sold Direct holding	▾

Showing 30 / 49 record groups in 2026. The complete set is available through the API.

Mineralys Therapeutics, Inc. · MLYS

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 49 purchase / sale groups and 30 of 119 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"MLYS","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.